145 related articles for article (PubMed ID: 10334256)
1. Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group.
Studd J; Pornel B; Marton I; Bringer J; Varin C; Tsouderos Y; Christiansen C
Lancet; 1999 May; 353(9164):1574-8. PubMed ID: 10334256
[TBL] [Abstract][Full Text] [Related]
2. Dose-ranging studies of a novel intranasal estrogen replacement therapy.
Panay N; Toth K; Pelissier C; Studd J
Maturitas; 2001 Jun; 38 Suppl 1():S15-22. PubMed ID: 11390120
[TBL] [Abstract][Full Text] [Related]
3. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms.
Mattsson LA; Christiansen C; Colau JC; Palacios S; Kenemans P; Bergeron C; Chevallier O; Von Holst T; Gangar K
Am J Obstet Gynecol; 2000 Mar; 182(3):545-52. PubMed ID: 10739506
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation, dose-finding and acceptability of AERODIOL, the pulsed estrogen therapy for treatment of climacteric symptoms.
Pelissier C; de Kervasdoue A; Chuong VT; Maugis EL; de Mouillac F; Breil MH; Moniot G; Zeitoun-Lepvrier G; Robin M; Rime B
Maturitas; 2001 Jan; 37(3):181-9. PubMed ID: 11173180
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic value and long-term safety of pulsed estrogen therapy.
Dören M; Azzawi FA; Donnez J; Van der Mooren MJ; Villero J; Gompel A
Maturitas; 2001 Jun; 38 Suppl 1():S23-30. PubMed ID: 11390121
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on estradiol-intranasal in the management of menopause.
Dooley M; Spencer CM; Ormrod D
Treat Endocrinol; 2002; 1(3):191-4. PubMed ID: 15799211
[TBL] [Abstract][Full Text] [Related]
7. Endometrial safety and tolerability of AERODIOL(R) (intranasal estradiol) for 1 year.
Gompel A; Bergeron C; Jondet M; Dhont M; Van der Mooren MJ; Toth KS; Panay N; Von Holst T
Maturitas; 2000 Oct; 36(3):209-15. PubMed ID: 11063903
[TBL] [Abstract][Full Text] [Related]
8. Estradiol-intranasal: a review of its use in the management of menopause.
Dooley M; Spencer CM; Ormrod D
Drugs; 2001; 61(15):2243-62. PubMed ID: 11772138
[TBL] [Abstract][Full Text] [Related]
9. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.
Nielsen TF; Ravn P; Pitkin J; Christiansen C
Maturitas; 2006 Jan; 53(2):184-90. PubMed ID: 16368471
[TBL] [Abstract][Full Text] [Related]
10. Clinical equivalence of intranasal estradiol and oral estrogens for postmenopausal symptoms.
Ozsoy M; Oral B; Ozsoy D
Int J Gynaecol Obstet; 2002 Nov; 79(2):143-6. PubMed ID: 12427399
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.
Rozenbaum H; Chevallier O; Moyal M; Durand G; Perineau M; This P;
Climacteric; 2002 Sep; 5(3):249-58. PubMed ID: 12419083
[TBL] [Abstract][Full Text] [Related]
12. Aerodiol versus the transdermal route: perspectives for patient preference.
Lopes P; Rozenberg S; Graaf J; Fernandez-Villoria E; Marianowski L
Maturitas; 2001 Jun; 38 Suppl 1():S31-9. PubMed ID: 11390122
[TBL] [Abstract][Full Text] [Related]
13. [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].
Genazzani AR; Cappagli B; Ciaponi M
Minerva Ginecol; 2003 Jun; 55(3):189-200. PubMed ID: 14581864
[TBL] [Abstract][Full Text] [Related]
14. Intranasal versus transdermal matrix oestrogen replacement in Australasian women.
Davis SR; Davison SL; Wilson S; Shepherd J; Lawton B
Maturitas; 2005 Jun; 51(2):163-71. PubMed ID: 15917157
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
[TBL] [Abstract][Full Text] [Related]
16. Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations.
Devissaguet JP; Brion N; Lhote O; Deloffre P
Eur J Drug Metab Pharmacokinet; 1999; 24(3):265-71. PubMed ID: 10716066
[TBL] [Abstract][Full Text] [Related]
17. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
Palacios S
Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women.
von Holst T; Salbach B
Maturitas; 2002 Mar; 41(3):231-42. PubMed ID: 11886769
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis prevention clinical study program.
Delmas P; Gimona A
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
[TBL] [Abstract][Full Text] [Related]
20. Initial 17beta-estradiol dose for treating vasomotor symptoms.
Notelovitz M; Lenihan JP; McDermott M; Kerber IJ; Nanavati N; Arce J
Obstet Gynecol; 2000 May; 95(5):726-31. PubMed ID: 10775738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
